Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm not sure how the point you're making is relevant. The AUM is important because it's hard to raise over $100 million dollars for a fund. You have to be a pretty sharp investor to get that done. The point is that some pretty sharp investors have bought half of this company.
The fact that funds with assets under management over 100 million now own half of Sunshine tells me everything about the potential here.
No, they have 16 million minus fees plus the warrants which will be converted giving them all the money that they need.
That is not what happened. The market was falling apart as you know and the medical research fund that bought 3 million worth of stock used their leverage to get a better price. Sunshine now has all the money they need with a small OS. We have never been in a better spot.
I agree with you 100%. I sometimes temper my statements because I don't want to seem like a pumper.
There is language in the first offering that says if there is a subsequent lower offering then the floor of the first offering warrant price drops to the second offering closing price. This does not affect the price of the first offering.
This is very good news for those that participated in the first offering. If the stock price goes up like I expect it to then this really won't affect anybody else.
Another great volume day yesterday. Aegis can promote the stock starting March 18th I think. However, the floor for warrant prices from the last offering drops to 2.22 because of the latest offering so we may see some dilution. It is going to be a roller coaster heading in to April. SBFM is going to make the smart/lucky day and swing traders a lot of money for the rest of March I bet.
I don't know. We could go back to $62 or we could be back to 50 cents. The science will tell us in which direction we will go. I am just excited to close this chapter and move on to the next one.
I will say this. The biggest clue to the direction that we are headed is that institutional investors now own half of this company.
I think in a year this could be worth 2 billion but our OS will be 15 million, so we should be at around 113 a share.
You are correct. There is a difference between an at the market offering and at the market pricing.
You are 100% correct. If the science isn't there in April then we are in big trouble with this investment.
Experts need to learn the difference between an "at-the-market offering" and a "securities purchase agreement with certain institutional and accredited investors" "priced at-the-market".
I will add this to the list.
OK, here is some info on the offering from this morning. I spoke to my friend at Aegis. He said the offering was only for qualified investment fund(s). That means the offering was taken down by a fund or funds who have at least 100 million under management. He can't give anymore information than that. He can't tell me who they are or if it is one fund or several funds.
This means that half of Sunshine is now owned by hedge funds/investment funds. This is hugely bullish imo.
Guess what? Aegis knows who the partners are here. We don't.
Next week (the 18th) Aegis can start promoting the stock and there will be analysts looking at Sunshine. If this stock is lower on the 25th then it is now, I will consider that to be very bad news. We shall see.
Somebody just bought in the company for a reason. Private offerings like that don't happen because the buyer thinks they will lose money. No, some entity just invested 3.6 million in Sunshine.
Who is the buyer? That is all that matters.
Everybody needs to relax. This was a private offering. I did not know about it and Aegis promised to keep me informed if I want to invest more.
Who invested in the company? Was it a big pharma partner? Was it somebody who can help the company move forward in the future? This could be a huge positive. We have to wait to find out.
I think yesterday a large pharma took a large position in Sunshine. We shall see. This would be a really smart risk to take at this point that would discount a future buyout greatly.
I spoke with the company yesterday, and they confirmed that the quiet period does in fact run through March 28th.
I said Nasdaq and their lawyers were wrong because the experts on Ihub said no quiet period existed. They reminded me that the experts on Ihub said that SBFM is a scam, SBFM was only renting the lab space in Georgia, and SBFM would never make it to Nasdaq.
I just don't know who to believe anymore. ;(
You lucky guy...I brought my average down to $30 but I did pick up a boat load of warrants.
I still think I will win big here though.
That would be the quiet period posted on the Nasdaq website endorsed by the corporate lawyers that actually does not exist according to the "experts".
This is the same stock that was valued at over 1 billion 3 years ago.
This is the same stock that is doing research with some of the best Universities in the world and the NIH and Dept. of Energy.
This is the same stock that just finished in vitro studies showing their drug kills 100% of chemo resistant cancers.
This is the same stock that is almost 30% owned by a fund run by medical doctors.
The current price does not matter- it never has. Once the science is revealed in April we will know where we are headed.
I think we blow past $60, but we shall see.
The underwriter profited..yes I know. However, if you don't think Aegis is going to pump Sunshine next week you are naive. The Aegis guys need to show a track record of profit for their investors. Book runners who create bag holders don't make money in the future.
You could be right. I don't know. Maybe a pump and dump got the ball rolling and now this is just traders playing the stock. I do know that Aegis could not have been happy with the drop in price and I fully expect them to recommend the stock very soon.
I thought this was a pump and dump. Now with volume 10x the OS, I don't know what to call this. I know news didn't leak because Camille is no longer IR and he is actually not even talking to people on the phone.
Hopefully, this is Aegis buying in the open market. We shall see.
wait until it is disclosed that a medical science fund is the largest owner of Sunshine common stock. Wait until Fast Track application news hits. This is nothing.
Yesterday, Sunshine had more cash on hand than the entire market cap. It doesn't take a genius to see that this stock is INCREDIBLY UNDERVALUED.
This may be a pump and dump, or it may not. You are incorrect to say that $5 a share here is out of line with reality though. I think arguably Sunshine is worth $20+.
Yep. I remember well. Today is a chat room pump and dump and that is ok. We will get a higher base (hopefully) and a lot of awareness.
I think this is a pump and dump from some chat room this morning, but that doesn't matter. Today traders will become aware of the stock and when news does come there will be more eyes on Sunshine. Good luck to us.
longer than you think. ;) Long enough to see the evolution of greedy people who have the patience of children.
The price of the stock does not matter. The only thing that matters is the value of the company. Where is the market cap going? If you know how to value companies than buying and holding will make you rich.
Slilaty is a guy that can take you places.
wtf are you talking about??? LOL, you run down management and now you are a cheerleader? Shorts aren't scared. Sunshine has a low float, and today is the day that traders start using this stock as a cash machine. It will go up and down ad nauseum.
On the 18th Aegis can recommend the stock. In April Slilaty can tell the world about his progress.
Then, all the disgruntled longs who call Slilaty a scammer can tell their friends how smart they were to buy this stock. LOL.
This company is worth 250 million + imo. Why is anybody surprised at this tiny move?
Facts like that don't matter, lol. They said it was a scam. They said we would never get to NASDAQ. They said that UGa was not participating in the studies. They said there would be no government funding. Now they say there is no quiet period.
Do you notice a trend?
We finally are on the right course. When the quiet period ends the science will be revealed and we will find our proper valuation.
but, but, but...the "experts" said that there was no quiet period. lol.
double bottom forming...good buy in my opinion.
Nope, you should read the article. Since you did not read it let me summarize for you.
Scott Pegan of UC Riverside is working on a project in conjunction with UGA that is funded by Sunshine Biopharma and the NIH. All of the work product falls under Slilaty's patent and is related to Pl4. Sunshine owns the resulting products which is why they are the INDUSTRY PARTNER.
You see, this is a UC Riverside press release because this work was done at UC Riverside. UC Riverside is not in charge of press releases for UGa. That would be stupid, right?
LMAO. This is going to be fun going forward.
Oh, so you think that UC Riverside is doing PR work for UGa? You think that the INDUSTRY PARTNER is actually a partner for somebody else?
LMAO. Good luck to you.
Anybody who read the article can clearly see that Pegan, Crich, UC Riverside, UGa, Sunshine Biopharma, the NIH, and the Dept of Energy are working together to solve the coronavirus problem. I think you should actually read the article.
https://news.ucr.edu/articles/2022/02/24/potential-antiviral-sars-and-sars-coronaviruses
From the article (apply Occam's Razor and understand that the simplest explanation for the words in the article is that you apply a dictionary for their meaning).
In the paper, the researchers demonstrate that these types of compounds can be pan inhibitors of PLpro and highlight their safety profiles at a cellular level.
“In particular, we push forward the development of a set of compounds from which a practical therapeutic may come,” Pegan said.
Pegan was joined in the research by several colleagues at the University of Georgia. Of these, David Crich led the compound synthesis team and served as co-designer of the compounds with Pegan; Ralph Tripp led the antiviral testing group; and Brian Cummings, now at Wayne State University, led the toxicology efforts.
The research was funded by the National Institutes of Health and industry partner Sunshine BioPharma. The structural biology data collection for the project was supported by the Department of Energy.
The research paper is titled “Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like Coronaviruses.”
UC Riverside clearly states that Sunshine Biopharma is their INDUSTRY PARTNER. (Get out your dictionary now and apply Occam's Razor).
The filings from the last year clearly say that Sunshine is moving to IND studies and applying for Fast Track for Adva-27a and Pl4. They can't do that without successful mice trials.
Good news is coming in my opinion.
I really don't understand why Sunshine is not issuing a PR or an 8K based on the information that was released by the University of California Riverside last week.
It is confirmed that UC Riverside (and Scott Pegan), the University of Georgia, the National Institute for Health, and the Department of Energy are collaborating on SBFM-PL4. It is confirmed that they believe they might have an answer for future coronavirus outbreaks.
I think whichever lawyers are advising Sunshine are making a mistake. I have been incredibly supportive of Sunshine but I don't support this decision to remain quiet after last Friday's article one bit.
I think you are correct. We need validation from other sources. We got some on Friday when we learned that Pegan and Sunshine are working with the NIH and Dept of Energy (along with UGa) on PL4.
We also desperately need one of the two platforms (adva or pl4) to achieve fast track status. Adva's argument for fast track is obvious- chemo resistant breast cancer or pancreatic cancer. I hope Pl4 is used for one of the secondary viruses being targeted. Fortunately for us, getting fast tracked is much more common than people might think.
https://www.advisory.com/daily-briefing/2019/07/10/fast-tracked#:~:text=FDA%20granted%20fast%2Dtracked%20approval,year%2C%20according%20to%20the%20Journal.
Last year we did not have enough money to move forward.
This year we have given up 2/3rd of our equity for the chance to move forward. If we did not strike that deal with Aegis we would be dead in the water.
Now, UC Riverside just told us that Sunshine is working with the NIH and Dept of Energy and they think they have a possible solution for the most lethal coronaviruses. We have the money for IND studies and phase 1 human trials, and we will probably get fast tracked.
Without a doubt, we are in a better position right now.
Many said we would never get to Nasdaq. Many said that Sunshine was not getting government funding. Many are saying we won't get past mice trials. They are wrong.